Suivre
Veronique Preat
Veronique Preat
Adresse e-mail validée de uclouvain.be
Titre
Citée par
Citée par
Année
PLGA-based nanoparticles: an overview of biomedical applications
F Danhier, E Ansorena, JM Silva, R Coco, A Le Breton, V Préat
Journal of controlled release 161 (2), 505-522, 2012
36662012
To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
F Danhier, O Feron, V Préat
Journal of controlled release 148 (2), 135-146, 2010
29632010
Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach
A des Rieux, V Fievez, M Garinot, YJ Schneider, V Préat
Journal of controlled release 116 (1), 1-27, 2006
15992006
RGD-based strategies to target alpha (v) beta (3) integrin in cancer therapy and diagnosis
F Danhier, A Le Breton, V Préat
Molecular pharmaceutics 9 (11), 2961-2973, 2012
10042012
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation
F Danhier, N Lecouturier, B Vroman, C Jérôme, J Marchand-Brynaert, ...
Journal of controlled release 133 (1), 11-17, 2009
7162009
Skin electroporation for transdermal and topical delivery
AR Denet, R Vanbever, V Préat
Advanced drug delivery reviews 56 (5), 659-674, 2004
6562004
Nanostructured lipid carriers: Promising drug delivery systems for future clinics
A Beloqui, MÁ Solinís, A Rodríguez-Gascón, AJ Almeida, V Préat
Nanomedicine: Nanotechnology, biology and medicine 12 (1), 143-161, 2016
6352016
Chitosan and chitosan derivatives in drug delivery and tissue engineering
R Riva, H Ragelle, A des Rieux, N Duhem, C Jérôme, V Préat
Chitosan for biomaterials II, 19-44, 2011
4712011
Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel
F Danhier, B Vroman, N Lecouturier, N Crokart, V Pourcelle, H Freichels, ...
Journal of Controlled Release 140 (2), 166-173, 2009
4282009
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
M Garinot, V Fiévez, V Pourcelle, F Stoffelbach, A des Rieux, L Plapied, ...
Journal of controlled release 120 (3), 195-204, 2007
4162007
Fate of polymeric nanocarriers for oral drug delivery
L Plapied, N Duhem, A des Rieux, V Préat
Current opinion in colloid & interface science 16 (3), 228-237, 2011
3742011
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance
C Bosquillon, C Lombry, V Preat, R Vanbever
Journal of controlled release 70 (3), 329-339, 2001
3712001
Transport of nanoparticles across an in vitro model of the human intestinal follicle associated epithelium
A des Rieux, EGE Ragnarsson, E Gullberg, V Préat, YJ Schneider, ...
European Journal of Pharmaceutical Sciences 25 (4-5), 455-465, 2005
3582005
An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells
A des Rieux, V Fievez, I Théate, J Mast, V Préat, YJ Schneider
european journal of pharmaceutical sciences 30 (5), 380-391, 2007
3562007
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
H Ragelle, F Danhier, V Préat, R Langer, DG Anderson
Expert opinion on drug delivery 14 (7), 851-864, 2017
3512017
Combined effect of PLGA and curcumin on wound healing activity
KK Chereddy, R Coco, PB Memvanga, B Ucakar, A des Rieux, ...
Journal of controlled release 171 (2), 208-215, 2013
3082013
In Vivo Methods for the Assessment of Topical Drug Bioavailability
C Herkenne, I Alberti, A Naik, YN Kalia, FX Mathy, V Préat, RH Guy
Pharmaceutical research 25, 87-103, 2008
3062008
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
A Lopes, G Vandermeulen, V Préat
Journal of Experimental & Clinical Cancer Research 38, 1-24, 2019
2892019
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ...
European Journal of Pharmaceutical Sciences 137, 104967, 2019
2822019
Stability study of nanoparticles of poly (ɛ-caprolactone), poly (d, l-lactide) and poly (d, l-lactide-co-glycolide)
D Lemoine, C Francois, F Kedzierewicz, V Preat, M Hoffman, P Maincent
Biomaterials 17 (22), 2191-2197, 1996
2821996
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20